Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TAIKO PHARMACEUTICAL CO LTD Raises Consolidated Mid-year Outlook for FY 2014


Wednesday, 9 Oct 2013 02:00am EDT 

TAIKO PHARMACEUTICAL CO LTD announced that it has raised its consolidated mid-year outlook for revenue from JPY 4,000 million to JPY 4,240 million, operating profit from JPY 1,100 million to JPY 1,420 million, ordinary profit from JPY 1,110 million to JPY 1,430 million, net profit from JPY 850 million to JPY 1,110 million and earning per share from JPY 66.98 to JPY 87.08 , for the fiscal year ending March 2014. The Company raised the outlook due to the increased sales, the impact of the lower yen, as well as the cost reduction, among others. 

Company Quote

1841.0
-44.0 -2.33%
24 Oct 2014